ASCO: Uneven US clinical trial spread leaves millions of women without access to breast cancer studies
Despite being more likely to be diagnosed with triple negative breast cancer (TNBC), Black women remain underrepresented in clinical trials across the U.S. While distance from trial sites may not…
